Craig Chang, MD
Surgery · Victoria, TXNPI 1306802814
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,572 of the $2,337 with a category attached, or 67.2%. TELA Bio, Inc. accounts for 75.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $1,651 and has fallen 93.9% since, to $101 in 2025. That places this record below the midpoint for surgery clinicians in TX, where the typical reported total is $2,700.
Across 32 payments — averaging $73.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$2K
- Baxter Healthcare$191
- Merit Medical Systems Inc$101
- Medtronic$53
- Endogastric Solutions, Inc$41
- Johnson & Johnson$30
- plus $154 from 9 others
What the payments were for
- Travel & lodging$1,57267%
- Food & beverage$76533%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 7 | $1,767 |
| Baxter Healthcare | 7 | $191 |
| Merit Medical Systems Inc | 3 | $101 |
| Medtronic | 1 | $53 |
| Endogastric Solutions, Inc | 2 | $41 |
| Johnson & Johnson | 2 | $30 |
| AMAG Pharmaceuticals, Inc. | 2 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Teleflex LLC | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $15 |
| RTI Surgical, Inc | 1 | $14 |
| Acell, Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,337 in reported general payments places this provider in the 45th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 25 | $228 |
| Pantoprazole Sodium | 20 | $82 |
Paid to pharmacies, not to this prescriber.
Other surgery in Victoria
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
- Nancy MarquezAustin$700K
- Sachin KukrejaDallas$640K
- Alejandro EsquivelAustin$631K
- Erik WilsonBellaire$610K
- Folahan AyoolaDenton$570K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.